Tetrahydrobenzimidazole derivatives and pharmaceutical compositi

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544105, 544331, 546121, 546159, 546168, 548139, 548184, 548185, 5483047, 5483051, 5483054, 5483057, 5483061, A61K 31505, A61K 3147, C07D23504, C07D23942, C07D40100

Patent

active

053449274

ABSTRACT:
A tetrahydrobenzimidazole derivative represented by formula (I): ##STR1## wherein Het represents a heterocyclic group which may be substituted with 1 to 3 substituents selected from the group consisting of a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a cycloalkyl-lower alkyl group, an aralkyl group, a lower alkoxy group, a nitro group, a hydroxyl group, a lower alkoxycarbonyl group, and a halogen atom; and X represents a single bond or --NH-- which is bonded to the carbon atom or nitrogen atom of the heterocyclic ring, or a pharmaceutically acceptable salt thereof.
The compound of formula (I) and a salt thereof exhibits antagonism against 5-HT.sub.3 receptor.

REFERENCES:
patent: 3772315 (1973-11-01), Regel et al.
patent: 3873558 (1975-03-01), Grenda et al.
patent: 3907700 (1983-09-01), Grier
patent: 4414214 (1989-11-01), Habichi et al.
patent: 4820757 (1989-04-01), Spang et al.
patent: 5008397 (1991-04-01), Spang et al.
patent: 5149700 (1992-09-01), Ellingboe et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tetrahydrobenzimidazole derivatives and pharmaceutical compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydrobenzimidazole derivatives and pharmaceutical compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrobenzimidazole derivatives and pharmaceutical compositi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1330274

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.